Mast cell activation disorder masquerading as pure red cell aplasia

International Journal of Hematology

Volumn 91, Issue 5, 2010, Pages 907-908

  Afrin, Lawrence B ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; ERYTHROPOIETIN; STEROID;

ADULT; ANAMNESIS; CASE REPORT; CELL ACTIVATION; CLINICAL EXAMINATION; DIAGNOSTIC TEST; FEMALE; HUMAN; LETTER; MAST CELL; MASTOCYTOSIS; PURE RED CELL ANEMIA; TREATMENT FAILURE; TREATMENT RESPONSE; MIDDLE AGED; PATHOLOGY; RED-CELL APLASIA, PURE;

FEMALE; HUMANS; MAST CELLS; MASTOCYTOSIS; MIDDLE AGED; RED-CELL APLASIA, PURE;

EID: 77954536874     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12185-010-0605-x     Document Type: Letter

References (7)

1. K Sawada N Fujishama M Hirokawa 2008 Acquired pure red cell aplasia: updated review of treatment Br J Haematol 142 4 505 514 10.1111/j.1365-2141. 2008.07216.x 1:CAS:528:DC%2BD1cXhtV2qsLnK 18510682 (Pubitemid 352020200)
2. Swerdlow SH, Campo E, Harris NL, et al., editors. WHO classification of tumours of haematopoietic and lymphoid tissues. France: IARC; 2008.
3. Roberts LJ, Anthony LB, Oates JA. Disorders of vasodilator hormones: carcinoid syndrome and mastocytosis. In: Wilson JD, Foster DW, Kronenberg HM, et al., editors. Williams textbook of endocrinology. 9th ed. Philadelphia: W. B. Saunders Company; 1998. p. 1718-32.
4. Ibelgaufts H. Mast cells. In: COPE: cytokines and cells online pathfinder encyclopaedia. 2010. http://www.copewithcytokines.de/cope.cgi?key=mast%20cells. Accessed 14 Mar 2010.
5. C Akin DD Metcalfe 2004 The biology of Kit in disease and the application of pharmacogenetics J Allergy Clin Immunol 114 1 13 19 10.1016/j.jaci.2004.04. 046 1:CAS:528:DC%2BD2cXlsVaqtL0%3D 15241338 (Pubitemid 39005112)
6. GJ Molderings UW Kolck C Scheurlen M Brüss J Homan I Von Kügelgen 2007 Multiple novel alterations in Kit tyrosine kinase in patients with gastrointestinally pronounced systemic mast cell activation disorder Scand J Gastroenterol 42 9 1045 1053 10.1080/00365520701245744 1:CAS:528: DC%2BD2sXpt1KisLY%3D 17710669 (Pubitemid 47301141)
7. A Pardanani M Elliott T Reeder, et al. 2003 Imatinib for systemic mast-cell disease Lancet 362 9383 535 536 10.1016/S0140-6736(03)14115-3 1:CAS:528:DC%2BD3sXmsVarur4%3D 12932387 (Pubitemid 36976719)